OBJECTIVE: To investigate the antibacterial effect of augmenting a biological dressing with polymer films containing silver nanoparticles. BACKGROUND: Biological dressings, such as Biobrane, are commonly used for treating partial-thickness wounds and burn injuries. Biological dressings have several advantages over traditional wound dressings. However, as many as 19% of wounds treated with Biobrane become infected, and, once infected, the Biobrane must be removed and a traditional dressing approach should be employed. Silver is a commonly used antimicrobial in wound care products, but current technology uses cytotoxic concentrations of silver in these dressings. We have developed a novel and facile technology that allows immobilization of bioactive molecules on the surfaces of soft materials, demonstrated here by augmentation of Biobrane with nanoparticulate silver. Surfaces modified with nanometer-thick polyelectrolyte multilayers (PEMs) impregnated with silver nanoparticles have been shown previously to result in in vitro antibacterial activity against Staphylococcus epidermidis at loadings of silver that are noncytotoxic. METHODS: We demonstrated that silver-impregnated PEMs can be nondestructively immobilized onto the surface of Biobrane (Biobrane-Ag) and determined the in vitro antibacterial activity of Biobrane-Ag with Staphylococcus aureus. In this study, we used an in vivo wound infection model in mice induced by topical inoculation of S aureus onto full-thickness 6-mm diameter wounds. After 72 hours, bacterial quantification was performed. RESULTS: Wounds treated with Biobrane-Ag had significantly (P < 0.001) fewer colony-forming units than wounds treated with unmodified Biobrane (more than 4 log10 difference). CONCLUSIONS: The results of our study indicate that immobilizing silver-impregnated PEMs on the wound-contact surface of Biobrane significantly reduces bacterial bioburden in full-thickness murine skin wounds. Further research will investigate whether this construct can be considered for human use.
OBJECTIVE: To investigate the antibacterial effect of augmenting a biological dressing with polymer films containing silver nanoparticles. BACKGROUND: Biological dressings, such as Biobrane, are commonly used for treating partial-thickness wounds and burn injuries. Biological dressings have several advantages over traditional wound dressings. However, as many as 19% of wounds treated with Biobrane become infected, and, once infected, the Biobrane must be removed and a traditional dressing approach should be employed. Silver is a commonly used antimicrobial in wound care products, but current technology uses cytotoxic concentrations of silver in these dressings. We have developed a novel and facile technology that allows immobilization of bioactive molecules on the surfaces of soft materials, demonstrated here by augmentation of Biobrane with nanoparticulate silver. Surfaces modified with nanometer-thick polyelectrolyte multilayers (PEMs) impregnated with silver nanoparticles have been shown previously to result in in vitro antibacterial activity against Staphylococcus epidermidis at loadings of silver that are noncytotoxic. METHODS: We demonstrated that silver-impregnated PEMs can be nondestructively immobilized onto the surface of Biobrane (Biobrane-Ag) and determined the in vitro antibacterial activity of Biobrane-Ag with Staphylococcus aureus. In this study, we used an in vivo wound infection model in mice induced by topical inoculation of S aureus onto full-thickness 6-mm diameter wounds. After 72 hours, bacterial quantification was performed. RESULTS: Wounds treated with Biobrane-Ag had significantly (P < 0.001) fewer colony-forming units than wounds treated with unmodified Biobrane (more than 4 log10 difference). CONCLUSIONS: The results of our study indicate that immobilizing silver-impregnated PEMs on the wound-contact surface of Biobrane significantly reduces bacterial bioburden in full-thickness murine skin wounds. Further research will investigate whether this construct can be considered for human use.
Authors: Paul Podsiadlo; Stephen Paternel; Jean-Marie Rouillard; Zhengfei Zhang; Jaebeom Lee; Jung-Woo Lee; Erdogan Gulari; Nicholas A Kotov Journal: Langmuir Date: 2005-12-06 Impact factor: 3.882
Authors: Robert D Galiano; Joseph Michaels; Michael Dobryansky; Jamie P Levine; Geoffrey C Gurtner Journal: Wound Repair Regen Date: 2004 Jul-Aug Impact factor: 3.617
Authors: Ankit Agarwal; Tahlia L Weis; Michael J Schurr; Nancy G Faith; Charles J Czuprynski; Jonathan F McAnulty; Christopher J Murphy; Nicholas L Abbott Journal: Biomaterials Date: 2009-10-28 Impact factor: 12.479
Authors: Maggie Herron; Ankit Agarwal; Patricia R Kierski; Diego F Calderon; Leandro B C Teixeira; Michael J Schurr; Christopher J Murphy; Charles J Czuprynski; Jonathan F McAnulty; Nicholas L Abbott Journal: Adv Healthc Mater Date: 2014-02-12 Impact factor: 9.933
Authors: Ariane R Brogliato; Paula A Borges; Janaina F Barros; Manuela Lanzetti; Samuel Valença; Nesser C Oliveira; Hélcio J Izário-Filho; Claudia F Benjamim Journal: Int Wound J Date: 2012-08-21 Impact factor: 3.315
Authors: Maggie Herron; Michael J Schurr; Christopher J Murphy; Jonathan F McAnulty; Charles J Czuprynski; Nicholas L Abbott Journal: Adv Healthc Mater Date: 2015-11-24 Impact factor: 9.933
Authors: Catlyn Blanchard; Lauren Brooks; Andrew Beckley; Jennifer Colquhoun; Stephen Dewhurst; Paul M Dunman Journal: Antimicrob Agents Chemother Date: 2015-11-23 Impact factor: 5.191
Authors: Andrew J Sawyer; Donna Wesolowski; Neeru Gandotra; Alexander Stojadinovic; Mina Izadjoo; Sidney Altman; Themis R Kyriakides Journal: Int J Pharm Date: 2013-05-29 Impact factor: 5.875
Authors: Rishabh Jain; Ankit Agarwal; Patricia R Kierski; Michael J Schurr; Christopher J Murphy; Jonathan F McAnulty; Nicholas L Abbott Journal: Biomaterials Date: 2012-10-22 Impact factor: 12.479
Authors: Kathleen M Guthrie; Ankit Agarwal; Leandro B C Teixeira; Richard R Dubielzig; Nicholas L Abbott; Christopher J Murphy; Harpreet Singh; Jonathan F McAnulty; Michael J Schurr Journal: J Burn Care Res Date: 2013 Nov-Dec Impact factor: 1.845